Skip to main content
. 2022 Mar 25;67:102824. doi: 10.1016/j.ctim.2022.102824

Table 3.

Comparison of number of patients with each of the presenting symptoms in both the groups.

Symptoms Days Mild-to-moderate
Odds ratios for symptom resolution [95% CI] Severe
Odds ratios for symptom resolution [95% CI]
Control arm Interventional arm Control arm Interventional arm
Cough D-1 (Baseline) 26(57.78) 24 (54.55) NA 6 (50) 5 (35.71) NA
D-3 16 (35.56) 4 (9.09) 5.7 [1.7, 18.7] * 2 (16.67) 1 (7.14) 2.6 [0.2, 32.9]
D-5 8 (17.78) 1 (2.27) 9.5 [1.1, 79.6] * 2 (16.67) 0 6.9 [0.3, 159.3]
Discharge 1 (2.2) 0 3.1 [0.1, 77.3] 0 0 1.2 [0.02, 62.9]
Breathlessness D-1 (Baseline) 18 (40) 12(27.27) NA 7 (58.33) 11 (78.57) NA
D-3 13 (28.89) 2 (4.55) 8.7 [1.8, 41.5] * 3 (25) 3 (21.43) 1.2 [0.2, 7.6]
D-5 4 (8.89) 1 (2.27) 5.5 [0.6, 49.1] 1 (8.33) 1 (7.14) 1.2 [0.07, 21.2]
Discharge 2 4.44) 0 5.2 [0.2, 112] 0 0 1.2 [0.02, 62.9]
Tastelessness D-1 (Baseline) 4 (8.89) 4 (9.1) NA 0 0 NA
D-3 3 (6.67) 1 (2.3) 3.1 [0.3, 31.4] 0 0 1.2 [0.02, 62.9]
D-5 1 (2.2) 0 3.1 [0.1, 77.3] 0 0 1.2 [0.02, 62.9]
Discharge 0 0 1 [0.01, 51] 0 0 1.2 [0.02, 62.9]
Fever D-1 (Baseline) 5 (11.11) 7 (15.9) NA 1 (8.33) 0 NA
D-3 4 (8.88) 2 (4.5) 2.1 [0.3 12] 0 0 1.2 [0.02, 62.9]
D-5 1 (2.22) 0 3.1 [0.1, 77] 0 0 1.2 [0.02, 62.9]
Discharge 0 0 1 [0.02, 51.5] 0 0 1.2 [0.02, 62.9]

NA-Not applicable; * - Statistically significant.